Lifodrox

Moxifloxacin, the active ingredient in Lifodrox, is a fluoroquinolone presented as an ophthalmic solution for ocular (topical) use. It treats bacterial conjunctivitis, keratitis and other bacterial ocular infections in patients requiring topical antibacterial therapy.

GNH USA supplies Lifodrox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin ophthalmic solution is indicated for bacterial infections of the eye, targeting the ocular surface and cornea. - Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of conjunctival inflammation. - Bacterial keratitis: eradicates causative organisms and promotes corneal healing. - Other bacterial ocular infections: provides broad‑spectrum coverage to treat miscellaneous bacterial eye infections.

Moxifloxacin ophthalmic solution may cause local and systemic adverse reactions, most of which are mild and transient. Common Side Effects: - Eye irritation: transient burning or stinging after drop application. - Redness: mild conjunctival hyperemia. - Blurred vision: temporary visual disturbance. Serious or Rare Side Effects: - Corneal ulceration: progressive epithelial breakdown that may threaten vision. - Severe allergic reaction: swelling, rash, or anaphylaxis. - Vision loss: sudden decrease in visual acuity.

Before using Lifodrox, consider the following precautions. - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: unknown; weigh benefits versus risks. - Contact lens wearers: remove lenses before administration and wait before reinserting. - Concomitant ocular surgery: postpone use until the wound has healed. - Allergy to fluoroquinolones: contraindicated. - Store at room temperature: keep in the original container, protect from light and moisture.

Moxifloxacin ophthalmic solution can interact with other medications; review the following. Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase risk of tendon toxicity. - Anticholinergic eye drops: may reduce moxifloxacin penetration. - Live vaccines: systemic absorption could theoretically affect immune response. Moderate Interactions (Monitor Closely): - Corticosteroid eye drops: may mask infection signs. - Non‑steroidal anti‑inflammatory eye drops: potential additive irritation. - Herbal supplements with quinolone activity: monitor for additive effects.